• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov8
Ernexa Therapeutics released FY2025 Q3 earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -0.1507
04:00
Ernexa Therapeutics released FY2025 9 Months Earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -3.064
04:00
Aug14
Ernexa Therapeutics released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -2.6089
03:00
Ernexa Therapeutics released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -0.6076
03:00
Jun25
Ernexa Hires Two Doctors for Ovarian Cancer and Autoimmune Disease Projects
13:03
Jun12
Charles Cherington Reports Acquisition of Ernexa Therapeutics Inc. Common Stock
00:35

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.24 M, EPS -0.1507

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -3.147 M, EPS -0.6076

Jun12
Reverse Stock Split(EST)

1-for-15 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
33.280
+147.99%
+19.860
PCLA
0.4175
+79.88%
+0.186
DTCK
0.3834
+61.16%
+0.152
ECDA
1.231
+56.85%
+0.445
UPC
6.250
+45.86%
+1.985
PAVS
2.070
+31.01%
+0.509
FJET
15.963
+28.73%
+3.600
ASPCR
0.2252
+25.11%
+0.045
SIDU
2.728
+24.00%
+0.540
PPSI
4.899
+20.96%
+0.830
View More